28 Jul Partner Spotlight: Pancreatic Cancer Action Network
Pancreatic Cancer Action Network’s enhanced patient services and clinical initiatives to transform the fight against pancreatic cancer
As the leader in the field, the Pancreatic Cancer Action Network (PanCAN) is aiming to transform the country’s system for pancreatic cancer healthcare delivery and medical research. The Clinical Trial Finder, an online tool that provides patients and healthcare professionals easy access to the most comprehensive and up-to-date database of pancreatic cancer clinical trials in the United States, is the latest initiative the organization is bringing to market for the pancreatic cancer community as part of its increased efforts to double survival of pancreatic cancer.
When dealing with pancreatic cancer, mortality can be swift so finding the right treatment as soon as possible is vital. By participating in clinical trials, patients not only have access to cutting-edge treatment but also have the opportunity to transform the treatment landscape for pancreatic cancer. According to Julie Fleshman, president and CEO of the Pancreatic Cancer Action Network, for years, the organization has had the most accurate database of pancreatic cancer trials and are thrilled to be able to now offer public access to patients and families and the healthcare community.
With a survival rate of just 7 percent, the need for effective treatment options is critical to pancreatic cancer patients. Clinical trials are often the best option for patients facing pancreatic cancer and are the only way to find better treatment options than what is currently available. The Pancreatic Cancer Action Network’s Clinical Trial Finder is the only tool of its kind and aims to assist patients and healthcare professionals alike in finding clinical trials that could be a beneficial course of treatment.
The availability of this service will significantly impact how patients and their healthcare teams are involved in pancreatic cancer clinical trial recruitment. With more people involved in clinical trials, the closer we’ll get to finding better treatments and drugs for our patient population.
The organization’s Clinical Trial Finder and Know Your Tumor initiatives were developed in order to improve the pancreatic cancer patient and caregiver experience and facilitate medical progress. Introduced this past January, the Know Your Tumor personalized medicine service offers tumor profiling to certain eligible patients and provides them access to molecular profiling of their tumor. The results from the molecular profiling tests are compiled into a report that is reviewed by a pancreatic cancer expert. The report highlights treatment options, including relevant clinical trials which could assist the treating oncologist in more precise and personalized treatment planning.
Personalized medicine is an emerging diagnostic tool for pancreatic cancer. Through the first phase of Know Your Tumor, nearly 50 percent of reports have revealed an actionable finding, meaning the information gained has the potential to impact treatment choices by identifying options that may have particular value in treating the patient’s specific tumor. Later this year, the organization will launch the Patient Registry, a research effort that will collect important information, such as molecular information learned through Know Your Tumor, critical to learning more about the pancreatic cancer patient population.
“By employing our comprehensive and proven approach and focusing our efforts for maximum impact, we are confident that we will make real progress in increasing understanding of and treatment for this devastating disease”, adds Fleshman.
Similar Posts You May Like To Read:
- How to Find the Right Clinical Trial
- Debunking Clinical Trial Myths: 5 Facts You Need To Know
- New Animated Video! How to Find & Pay for Clinical Trials
- 4,000 Cancer Clinical Trials: Which ONE is Right for Me?
- When You Don’t Qualify for a Clinical Trial: Expanded Access Might Help
- Do You Have Rights in a Clinical Trial?
- Clinical Treatment Act: Support and Progress
- Pancreatic Cancer Deaths Surpass Breast Cancer; It’s Time to Wage Hope